Literature DB >> 14600579

Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women.

Lytt I Gardner1, Robert S Klein, Lynda A Szczech, Ruby M Phelps, Karen Tashima, Anne M Rompalo, Paula Schuman, Ramses F Sadek, Tony C Tong, Alan Greenberg, Scott D Holmberg.   

Abstract

BACKGROUND: The rates and risk factors for overall and medical condition-specific hospitalizations in HIV-positive women have not been examined in detail or compared with rates in risk factor-matched HIV-negative women.
OBJECTIVE: To determine the rates and risk factors for overall and condition-specific hospitalizations.
METHODS: Prospective cohort study of 885 HIV-positive women and 425 HIV-negative women followed for semiannual research visits between 1993 and 2000 in 4 urban locations in the United States. Outcome measures were hospitalization diagnoses with diabetes mellitus, nonacute renal conditions, cardiovascular conditions, liver conditions, AIDS defining conditions, and overall hospitalizations. Clinical and laboratory risk factors were assessed at research visits every 6 months, and effects of risk factors on hospitalization rates were calculated using generalized estimating equations and Poisson regression.
RESULTS: Renal laboratory abnormalities, hypertension, and clinical AIDS were each associated with 3 of the 5 condition-specific hospitalization rates. Over time, diabetes-, nonacute renal-, and cardiovascular-related rates were flat or slightly increased and liver-related rates were significantly increased in HIV-positive women. Hospitalization rates with an AIDS-defining condition declined sharply in the latter half of the study period.
CONCLUSIONS: In this population of largely African-American, inner-city, HIV-infected women, renal abnormalities, hypertension, and hepatitis C virus infection were common. Rate ratios indicated that "non-AIDS" risk factors were important predictors of hospitalization. In the highly active antiretroviral therapy era, clinicians must pay attention to these risk factors for morbidity and should closely monitor renal abnormalities, hypertension, and hepatitis status.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14600579     DOI: 10.1097/00126334-200311010-00011

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  22 in total

Review 1.  The impact of disease stage on direct medical costs of HIV management: a review of the international literature.

Authors:  Adrian Levy; Karissa Johnston; Lieven Annemans; Andrea Tramarin; Julio Montaner
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

2.  Modelling the budget impact of darunavir in the treatment of highly treatment-experienced, HIV-infected adults in France.

Authors:  Xavier Colin; Antoine Lafuma; Dominique Costagliola; Erik Smets; Josephine Mauskopf; Pascal Guillon
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 3.  The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis.

Authors:  Christina M Wyatt; Carlos Malvestutto; Steven G Coca; Paul E Klotman; Chirag R Parikh
Journal:  AIDS       Date:  2008-09-12       Impact factor: 4.177

4.  The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals.

Authors:  Matthew S Freiberg; Debbie M Cheng; Kevin L Kraemer; Richard Saitz; Lewis H Kuller; Jeffrey H Samet
Journal:  AIDS       Date:  2007-01-11       Impact factor: 4.177

5.  Albuminuria as a marker of cardiovascular risk in HIV-infected individuals receiving stable antiretroviral therapy.

Authors:  Chawat Tongma; Cecilia M Shikuma; Beau K Nakamoto; Kalpana J Kallianpur; Tracie M Umaki; Jason D Barbour; Lishomwa Ndhlovu; Nisha I Parikh; Dominic C Chow
Journal:  Hawaii J Med Public Health       Date:  2013-09

6.  Trends and causes of hospitalizations among HIV-infected persons during the late HAART era: what is the impact of CD4 counts and HAART use?

Authors:  Nancy F Crum-Cianflone; Greg Grandits; Sara Echols; Anuradha Ganesan; Michael Landrum; Amy Weintrob; Robert Barthel; Brian Agan
Journal:  J Acquir Immune Defic Syndr       Date:  2010-07       Impact factor: 3.731

7.  The association between alcohol consumption and prevalent cardiovascular diseases among HIV-infected and HIV-uninfected men.

Authors:  Matthew S Freiberg; Kathleen A McGinnis; Kevin Kraemer; Jeffrey H Samet; Joseph Conigliaro; R Curtis Ellison; Kendall Bryant; Lewis H Kuller; Amy C Justice
Journal:  J Acquir Immune Defic Syndr       Date:  2010-02       Impact factor: 3.731

8.  Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.

Authors:  Clara Y Jones; Camille A Jones; Ira B Wilson; Tamsin A Knox; Andrew S Levey; Donna Spiegelman; Sherwood L Gorbach; Frederick Van Lente; Lesley A Stevens
Journal:  Am J Kidney Dis       Date:  2008-05-02       Impact factor: 8.860

Review 9.  Renal disease in patients with HIV infection: epidemiology, pathogenesis and management.

Authors:  Derek M Fine; Mark A Perazella; Gregory M Lucas; Mohamed G Atta
Journal:  Drugs       Date:  2008       Impact factor: 9.546

10.  Microalbuminuria in HIV infection.

Authors:  Lynda Anne Szczech; Carl Grunfeld; Rebecca Scherzer; Jesse A Canchola; Charles van der Horst; Stephen Sidney; David Wohl; Michael G Shlipak
Journal:  AIDS       Date:  2007-05-11       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.